• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Addus HomeCare Announces Second Quarter 2024 Financial Results

    8/5/24 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care
    Get the next $ADUS alert in real time by email

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the second quarter and six months ended June 30, 2024.

    Second Quarter 2024 Highlights:

    • Net Service Revenues Increased 10.4% to $286.9 Million
    • Net Income of $18.1 Million, or $1.10 per Diluted Share
    • Adjusted Net Income per Diluted Share Increased to $1.35
    • Adjusted EBITDA Increased 24.7% to $35.3 Million
    • Cash Flow from Operations of $18.8 Million
    • Announced a Definitive Agreement to Acquire the Personal Care Operations of Gentiva
    • Announced a Definitive Agreement to Sell the Company's New York Operations
    • Completed a Public Offering of 1,725,000 Shares of Common Stock for net proceeds of approximately $176.1 million

    Overview

    Net service revenues were $286.9 million for the second quarter of 2024, a 10.4% increase compared with $260.0 million for the second quarter of 2023. Net income was $18.1 million for the second quarter of 2024, compared with $14.9 million for the second quarter of 2023, while net income per diluted share was $1.10 compared with $0.91 for the same period a year ago. Adjusted EBITDA increased 24.7% to $35.3 million for the second quarter of 2024 from $28.3 million for the second quarter of 2023. Adjusted net income per diluted share was $1.35 for the second quarter of 2024 compared with $1.07 for the second quarter of 2023. Adjusted net income per diluted share for the second quarter of 2024 excludes acquisition expenses of $0.13 and stock-based compensation expense of $0.12 (See the end of press release for a reconciliation of all non-GAAP and GAAP financial measures.)

    For the first six months of 2024, net service revenues increased 11.0% to $567.7 million from $511.6 million for the prior-year period. Net income was $33.9 million for the first six months of 2024 compared with $27.5 million for the same period in 2023, and net income per diluted share was $2.06 compared with $1.69 per diluted share. Adjusted EBITDA increased 24.2% to $67.7 million for the first six months of 2024 from $54.6 million for the first six months of 2023. Adjusted net income was $42.1 million for the first six months of 2024 compared with $33.4 million for the first six months of 2023, while adjusted net income per diluted share was $2.56 compared with $2.05 for the prior-year period.

    Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, "Addus delivered another strong financial and operating performance for the second quarter of 2024, demonstrating consistent execution of our growth strategy. Our results were highlighted by top line revenue growth of 10.4% and adjusted EBITDA growth of 24.7% over the same period last year. The growing recognition of the value and cost-effectiveness of home-based care has supported robust demand for our services. Addus is well positioned to meet this demand as we continue to expand our market coverage and leverage our proven operating model across the continuum of home-based care. Our team has done an exceptional job in providing quality care for a growing number of patients and clients in the home, while allowing us to deliver consistent financial results.

    "Our strong organic growth was led by our personal care services, which accounted for 74.2% of our revenues for the second quarter. On a same-store basis, personal care revenues increased 8.8% over the same period last year, reflecting both higher volumes and rate increases in key markets. We also benefitted from a stable labor environment, and we continued to see our investments in hiring and onboarding processes contribute to a higher number of billable hours.

    "Our second quarter 2024 results included the operations from Tennessee Quality Care, a provider of home health, hospice, and private duty nursing services, which we acquired August 1, 2023. Our hospice care business, which contributed 19.5% of our revenues for the second quarter, has shown steady improvement with 6.3% organic revenue growth and higher admissions, patient days, and revenue per patient day compared with the second quarter of last year. We are also pleased that our home health business, which is our smallest segment, returned to positive growth trends with higher same-store revenue, admissions and volumes compared with the second quarter of 2023," added Allison.

    Acquisitions Support Continued Growth

    "In addition to our strong organic growth opportunities, acquisitions represent a key driver in expanding our market reach. In the second quarter, we announced a definitive agreement to acquire the personal care operations of Gentiva for an anticipated purchase price, after customary purchase price adjustments, of approximately $350.0 million. Based in Atlanta, Georgia, Gentiva provides personal care services to over 16,000 patients per day in a seven-state service area of Texas, Arkansas, Missouri, California, Arizona, Tennessee and North Carolina. We expect to close the transaction in the fourth quarter of 2024, following the completion of regulatory approvals and subject to customary closing conditions.

    "The Gentiva acquisition fits squarely into our growth strategy to leverage our strong personal care experience to build scale in existing markets as well as enter select new markets where we can immediately establish a significant presence. We are excited about the opportunity to expand our personal care market coverage in seven states, including Texas and Missouri, which are new markets for Addus, and where we will be the largest provider in Texas. We will also continue to look for accretive operations that provide the opportunity to add complementary clinical services. As we add more coverage density in select markets, we have the ability to participate in additional value-based contracting models, as payors continue to recognize the cost benefits and high quality of our home-based care services.

    "Following the recently announced divestiture of our New York operations, where our ability to pursue our strategy to develop multiple levels of care was substantially limited, we look forward to continuing to pursue acquisition growth opportunities in markets that are consistent with our strategic vision," added Allison.

    Cash and Liquidity

    As of June 30, 2024, the Company had cash of $173.3 million, with capacity and availability under its revolving credit facility of $504.4 million and $496.4 million, respectively. Net cash provided by operating activities was $18.8 million for the second quarter of 2024.

    On June 28, 2024, the Company completed a public offering of 1,725,000 shares of common stock at $108.00 per share. The net proceeds from the offering to Addus, after deducting underwriting discounts and commissions and estimated offering expenses, were approximately $176.1 million. The Company used approximately $81.4 million of the net proceeds for the repayment of all indebtedness outstanding under its credit facility and the remainder will be used for general corporate purposes, including funding the Gentiva acquisition and any future acquisitions or investments.

    Looking Ahead

    Allison added, "We are pleased with the momentum in our business, supported by the growing demand for our home-based care services as more consumers and families depend on Addus to receive safe, quality care in the preferred setting of their home. We are fortunate to have a great team of dedicated caregivers who support our mission and represent Addus in the marketplace. They are the reason for our success and provide us with confidence in our future growth. Together, we look forward to the opportunities before us to extend our reach to support more clients and patients with the care our services provide."

    Non-GAAP Financial Measures

    The information provided in this release includes adjusted net income, adjusted EBITDA, and adjusted net income per diluted share, which are non-GAAP financial measures. The Company defines adjusted net income as net income before acquisition expenses, stock-based compensation expenses, restructure and other non-recurring costs and retroactive rate increases from New York. The Company defines adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition expense, stock-based compensation expense, restructure and other non-recurring costs and retroactive rate increases from New York. The Company defines adjusted net income per diluted share as net income per share, adjusted for acquisition expenses, stock-based compensation expense, restructure and other non-recurring costs, and retroactive rate increases from New York. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted net income per share to net income per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted net income per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company's operating performance, to provide investors with insight and consistency in the Company's financial reporting and to present a basis for comparison of the Company's business operations among periods, and to facilitate comparison with the results of the Company's peers.

    Conference Call

    Addus will host a conference call on Tuesday, August 6, 2024, at 9:00 a.m. Eastern time. To access the live call, dial (833-629-0620) (international dial-in number is (412-317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on August 13, 2024, by dialing (877) 344-7529 (international dial-in number is (412) 317-0088) and entering pass code 4781847.

    A live broadcast of Addus HomeCare's conference call will be available under the Investor Relations section of the Company's website: www.addus.com. An online replay will also be available on the Company's website for one month, beginning approximately two hours following the conclusion of the live broadcast.

    Forward-Looking Statements

    Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as "preliminary," "continue," "expect," and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare's relationships with referral sources, increased competition for Addus HomeCare's services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any security breaches, cyber-attacks, loss of data or cybersecurity threats or incidents, and other risks set forth in the Risk Factors section in Addus HomeCare's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 27, 2024, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).

    About Addus HomeCare

    Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare's consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare's payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 49,500 consumers through 214 locations across 22 states. For more information, please visit www.addus.com.

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Condensed Consolidated Statements of Income
    (amounts and shares in thousands, except per share data)
    (Unaudited)
     
    Income Statement Information:

    For the Three Months

    Ended June 30,

     

    For the Six Months

    Ended June 30,

    2024

     

    2023

     

    2024

     

    2023

     
    Net service revenues

    $

    286,922

    $

    259,980

    $

    567,668

    $

    511,579

    Cost of service revenues

     

    193,764

     

     

    177,662

     

     

    386,333

     

     

    350,846

     

     
    Gross profit

     

    93,158

     

     

    82,318

     

     

    181,335

     

     

    160,733

     

     

    32.5

    %

     

    31.7

    %

     

    31.9

    %

     

    31.4

    %

    General and administrative expenses

     

    63,576

     

     

    57,397

     

     

    124,639

     

     

    113,757

     

    Depreciation and amortization

     

    3,401

     

     

    3,382

     

     

    6,870

     

     

    6,829

     

    Total operating expenses

     

    66,977

     

     

    60,779

     

     

    131,509

     

     

    120,586

     

     
    Operating income

     

    26,181

     

     

    21,539

     

     

    49,826

     

     

    40,147

     

     
    Total interest expense, net

     

    1,640

     

     

    2,040

     

     

    3,975

     

     

    4,395

     

     
    Income before income taxes

     

    24,541

     

     

    19,499

     

     

    45,851

     

     

    35,752

     

    Income tax expense

     

    6,462

     

     

    4,647

     

     

    11,942

     

     

    8,225

     

     
    Net income

    $

    18,079

     

    $

    14,852

     

    $

    33,909

     

    $

    27,527

     

     
    Net income per diluted share:

    $

    1.10

     

    $

    0.91

     

    $

    2.06

     

    $

    1.69

     

     
     
    Weighted average number of common shares outstanding:
    Diluted

     

    16,498

     

     

    16,283

     

     

    16,449

     

     

    16,304

     

     
    Cash Flow Information:

    For the Three Months

    Ended June 30,

     

    For the Six Months

    Ended June 30,

    2024

     

    2023

     

    2024

     

    2023

     
    Net cash provided by operating activities

    $

    18,813

     

    $

    41,614

     

    $

    57,491

     

    $

    60,413

     

    Net cash provided by (used in) investing activities

     

    3,548

     

     

    (969

    )

     

    1,798

     

     

    (2,711

    )

    Net cash provided by (used in) financing activities

     

    74,225

     

     

    (30,000

    )

     

    49,225

     

     

    (53,475

    )

     
    Net change in cash

     

    96,586

     

     

    10,645

     

     

    108,514

     

     

    4,227

     

    Cash at the beginning of the period

     

    76,719

     

     

    73,543

     

     

    64,791

     

     

    79,961

     

    Cash at the end of the period

    $

    173,305

     

    $

    84,188

     

    $

    173,305

     

    $

    84,188

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Condensed Consolidated Balance Sheets
    (Amounts in thousands)
    (Unaudited)
     

    June 30,

    2024

     

    2023

     
    Assets
     
    Current assets
    Cash

    $

    173,305

    $

    84,188

    Accounts receivable, net

     

    109,195

     

     

    104,252

     

    Prepaid expenses and other current assets

     

    12,488

     

     

    19,350

     

     
    Total current assets

     

    294,988

     

     

    207,790

     

     
    Property and equipment, net

     

    23,381

     

     

    19,607

     

     
    Other assets
    Goodwill

     

    663,851

     

     

    583,656

     

    Intangible assets, net

     

    88,398

     

     

    68,859

     

    Operating lease assets

     

    44,145

     

     

    48,472

     

    Other long-term assets

     

    1,791

     

     

    -

     

    Total other assets

     

    798,185

     

     

    700,987

     

     
    Total assets

    $

    1,116,554

     

    $

    928,384

     

     
    Liabilities and stockholders' equity
     
    Current liabilities
    Accounts payable

    $

    20,188

     

    $

    20,699

     

    Accrued payroll

     

    55,102

     

     

    47,795

     

    Accrued expenses

     

    35,633

     

     

    31,966

     

    Operating lease liabilities - current portion

     

    11,224

     

     

    11,334

     

    Government stimulus advance

     

    13,000

     

     

    9,959

     

    Accrued workers compensation

     

    12,385

     

     

    12,149

     

    Total current liabilities

     

    147,532

     

     

    133,902

     

     
    Long-term debt, less current portion, net of debt issuance costs

     

    -

     

     

    78,702

     

    Long-term lease liability, less current portion

     

    38,359

     

     

    43,214

     

    Other long-term liabilities

     

    9,008

     

     

    6,215

     

    Total long-term liabilities

     

    47,367

     

     

    128,131

     

     
    Total liabilities

     

    194,899

     

     

    262,033

     

     
    Total stockholders' equity

     

    921,655

     

     

    666,351

     

     
    Total liabilities and stockholders' equity

    $

    1,116,554

     

    $

    928,384

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Net Service Revenue by Segment
    (Amounts in thousands)
    (Unaudited)
     

    For the Three Months

    Ended June 30,

     

    For the Six Months

    Ended June 30,

    2024

     

    2023

     

    2024

     

    2023

    Net Service Revenues by Segment
     
    Personal Care

    $

    212,817

    $

    198,314

    $

    420,820

    $

    388,346

    Hospice

     

    56,030

     

     

    50,210

     

     

    111,893

     

     

    99,292

     

    Home Health

     

    18,075

     

     

    11,456

     

     

    34,955

     

     

    23,941

     

    Total Revenue

    $

    286,922

     

    $

    259,980

     

    $

    567,668

     

    $

    511,579

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Key Statistical and Financial Data (Unaudited)
    Key Statistical and Financial Data (Unaudited)

    For the Three Months

    Ended June 30,

     

    For the Six Months

    Ended June 30,

    2024

     

    2023

     

    2024

     

    2023

     
     
    Personal Care
     
    States served at period end

     

    -

     

     

    -

     

     

    21

     

     

    21

     

    Locations at period end

     

    -

     

     

    -

     

     

    153

     

     

    157

     

    Average billable census total

     

    37,993

     

     

    39,099

     

     

    37,854

     

     

    38,707

     

    Billable hours (in thousands)

     

    7,732

     

     

    7,681

     

     

    15,322

     

     

    15,274

     

    Average billable hours per census per month

     

    67.7

     

     

    65.3

     

     

    67.4

     

     

    65.6

     

    Billable hours per business day

     

    118,956

     

     

    118,177

     

     

    117,862

     

     

    117,491

     

    Revenues per billable hour

    $

    27.47

     

    $

    25.57

     

    $

    27.41

     

    $

    25.27

     

    Organic growth
    - Revenue

     

    8.8

    %

     

    12.6

    %

     

    9.3

    %

     

    11.7

    %

     
    Hospice
     
    Locations served at period end

     

    -

     

     

    -

     

     

    38

     

     

    34

     

    Admissions

     

    3,194

     

     

    3,076

     

     

    6,666

     

     

    6,400

     

    Average daily census

     

    3,477

     

     

    3,225

     

     

    3,418

     

     

    3,210

     

    Average discharge length of stay

     

    92.6

     

     

    94.4

     

     

    91.1

     

     

    90.9

     

    Patient days

     

    316,451

     

     

    293,502

     

     

    622,081

     

     

    581,053

     

    Revenue per patient day

    $

    179.47

     

    $

    174.32

     

    $

    181.10

     

    $

    175.26

     

    Organic growth
    - Revenue

     

    6.3

    %

     

    (1.1

    )%

     

    6.1

    %

     

    0.5

    %

    - Average daily census

     

    1.7

    %

     

    (3.2

    )%

     

    0.4

    %

     

    1.4

    %

     
    Home Health
     
    Locations served at period end

     

    -

     

     

    -

     

     

    23

     

     

    13

     

    New Admissions

     

    4,933

     

     

    3,439

     

     

    9,820

     

     

    7,332

     

    Recertifications

     

    3,277

     

     

    1,595

     

     

    6,445

     

     

    3,144

     

    Total Volume

     

    8,210

     

     

    5,034

     

     

    16,265

     

     

    10,476

     

    Visits

     

    111,053

     

     

    68,293

     

     

    217,984

     

     

    146,121

     

    Organic growth
    - Revenue

     

    1.6

    %

     

    (10.9

    )%

     

    (7.1

    )%

     

    0.7

    %

    - New admissions

     

    9.4

    %

     

    (17.5

    )%

     

    2.3

    %

     

    (10.5

    )%

    - Volume

     

    6.9

    %

     

    (11.8

    )%

     

    1.7

    %

     

    (10.9

    )%

     
    Percentage of Revenues by Payor:
     
    Personal Care
     
    State, local and other governmental programs

     

    53.1

    %

     

    50.6

    %

     

    52.5

    %

     

    50.4

    %

    Managed care organizations

     

    44.2

     

     

    46.0

     

     

    44.8

     

     

    46.1

     

    Private duty

     

    1.7

     

     

    2.2

     

     

    1.8

     

     

    2.2

     

    Commercial

     

    0.7

     

     

    0.8

     

     

    0.7

     

     

    0.9

     

    Other

     

    0.3

    %

     

    0.4

    %

     

    0.2

    %

     

    0.4

    %

     
    Hospice
     
    Medicare

     

    91.2

    %

     

    90.7

    %

     

    91.0

    %

     

    90.8

    %

    Commercial

     

    5.1

     

     

    5.4

     

     

    5.3

     

     

    5.3

     

    Managed care organizations

     

    3.4

     

     

    3.1

     

     

    3.3

     

     

    3.2

     

    Other

     

    0.3

    %

     

    0.8

    %

     

    0.4

    %

     

    0.7

    %

     
    Home Health
     
    Medicare

     

    69.3

    %

     

    76.1

    %

     

    69.2

    %

     

    75.1

    %

    Managed care organizations

     

    25.9

     

     

    19.6

     

     

    26.0

     

     

    20.0

     

    Commercial

     

    4.2

     

     

    3.8

     

     

    4.1

     

     

    4.5

     

    Other

     

    0.6

    %

     

    0.5

    %

     

    0.7

    %

     

    0.4

    %

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Reconciliation of Non-GAAP Financial Measures
    (Amounts in thousands, except per share data)
    (Unaudited) (1)

     

     

     

     

     

     

     

    For the Three Months

    Ended June 30,

     

    For the Six Months

    Ended June 30,

    2024

     

    2023

     

    2024

     

    2023

    Reconciliation of Adjusted EBITDA to Net Income: (1)
     
    Net income

    $

    18,079

     

    $

    14,852

     

    $

    33,909

     

    $

    27,527

     

     
    Interest expense, net

     

    1,640

     

     

    2,040

     

     

    3,975

     

     

    4,395

     

    (Gain) on sale of assets

     

    (5

    )

     

    (3

    )

     

    (5

    )

     

    (3

    )

    Income tax expense

     

    6,462

     

     

    4,647

     

     

    11,942

     

     

    8,225

     

    Depreciation and amortization

     

    3,401

     

     

    3,382

     

     

    6,870

     

     

    6,829

     

    Impact of retroactive New York rate increase

     

    -

     

     

    (1,090

    )

     

    -

     

     

    (868

    )

    Acquisition expenses

     

    2,864

     

     

    1,782

     

     

    5,575

     

     

    3,029

     

    Stock-based compensation expense

     

    2,856

     

     

    2,613

     

     

    5,474

     

     

    5,259

     

    Restructure and other non-recurring costs

     

    -

     

     

    75

     

     

    -

     

     

    170

     

    Adjusted EBITDA

    $

    35,297

     

    $

    28,298

     

    $

    67,740

     

    $

    54,563

     

     
     
    Reconciliation of Adjusted Net Income to Net Income: (2)
     
    Net income

    $

    18,079

     

    $

    14,852

     

    $

    33,909

     

    $

    27,527

     

     
    (Gain) on sale of assets

     

    (5

    )

     

    (3

    )

     

    (5

    )

     

    (3

    )

    Impact of retroactive New York rate increase

     

    -

     

     

    (1,090

    )

     

    -

     

     

    (868

    )

    Acquisition expenses

     

    2,864

     

     

    1,782

     

     

    5,575

     

     

    3,029

     

    Stock-based compensation expense

     

    2,856

     

     

    2,613

     

     

    5,474

     

     

    5,259

     

    Restructure and other non-recurring costs

     

    -

     

     

    75

     

     

    -

     

     

    170

     

    Tax Effect

     

    (1,506

    )

     

    (819

    )

     

    (2,876

    )

     

    (1,745

    )

     
    Adjusted Net Income

    $

    22,288

     

    $

    17,410

     

    $

    42,077

     

    $

    33,369

     

     
     
    Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (3)
     
    Net income per diluted share

    $

    1.10

     

    $

    0.91

     

    $

    2.06

     

    $

    1.69

     

     
    Impact of retroactive New York rate increase per diluted share

     

    -

     

     

    (0.05

    )

     

    -

     

     

    (0.04

    )

    Acquisition expenses per diluted share

     

    0.13

     

     

    0.08

     

     

    0.25

     

     

    0.14

     

    Restructure and other non-recurring costs per diluted share

     

    -

     

     

    -

     

     

    -

     

     

    0.01

     

    Stock-based compensation expense per diluted share

     

    0.12

     

     

    0.13

     

     

    0.25

     

     

    0.25

     

     
    Adjusted net income per diluted share

    $

    1.35

     

    $

    1.07

     

    $

    2.56

     

    $

    2.05

     

     
    Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (4)
     
    Net service revenues

    $

    286,922

     

    $

    259,980

     

    $

    567,668

     

    $

    511,579

     

     
    Revenues associated with the closure of certain sites

     

    -

     

     

    (542

    )

     

    -

     

     

    (1,066

    )

     
    Adjusted net service revenues

    $

    286,922

     

    $

    259,438

     

    $

    567,668

     

    $

    510,513

     

     
    Footnotes:
    (1) We define Adjusted EBITDA as earnings before net interest expense, income tax expense, depreciation and amortization, acquisition expenses, stock-based compensation expense, restructure expenses and other non-recurring costs, gain on the sale of assets, and retroactive rate increases from New York. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
     
    (2) We define Adjusted Net Income as net income before acquisition expenses, stock-based compensation expense, restructure and other non-recurring costs, gain on the sale of assets, and retroactive rate increases from New York. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
     
    (3) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition expenses, stock-based compensation expense and restructure and other non-recurring costs, gain on the sale of assets, and retroactive rate increases from New York. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
     
    (4) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240805528942/en/

    Get the next $ADUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADUS

    DatePrice TargetRatingAnalyst
    1/7/2026$135.00Buy
    Truist
    11/13/2025$120.00Market Perform
    BMO Capital Markets
    9/2/2025$145.00Buy
    UBS
    12/16/2024$150.00Mkt Outperform
    JMP Securities
    10/11/2024$150.00Overweight
    KeyBanc Capital Markets
    6/28/2024$136.00Outperform
    Macquarie
    4/23/2024$83.00Equal Weight → Underweight
    Barclays
    3/6/2024$88.00Equal Weight
    Barclays
    More analyst ratings

    $ADUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Raines Monica decreased direct ownership by 18% to 12,045 units (SEC Form 5)

    5 - Addus HomeCare Corp (0001468328) (Issuer)

    2/12/26 5:00:25 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Director Lopez Esteban sold $17,278 worth of shares (150 units at $115.18), decreasing direct ownership by 4% to 3,700 units (SEC Form 4)

    4 - Addus HomeCare Corp (0001468328) (Issuer)

    12/16/25 4:30:25 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Director Lopez Esteban sold $18,721 worth of shares (166 units at $112.78), decreasing direct ownership by 4% to 3,850 units (SEC Form 4)

    4 - Addus HomeCare Corp (0001468328) (Issuer)

    12/8/25 4:30:33 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Addus HomeCare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the fourth quarter and year-ended December 31, 2025, on Monday, February 23, 2026, after the market close. Addus HomeCare will host a conference call on Tuesday, February 24, 2026, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather Dixon, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available

    2/9/26 11:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare to Participate in Upcoming Investor Conferences in November

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its participation at the following investor conferences in November: 2025 UBS Global Healthcare Conference in Palm Beach Gardens, Florida. Dirk Allison, Chairman and Chief Executive Officer, Heather Dixon, President and Chief Operating Officer and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 9:15 a.m. Central Time / 10:15 a.m. Eastern Time on Wednesday, November 12, 2025. 2025 Stephens Annual Investment Conference in Nashville, Tennessee. Dirk Allison, Chairman and Chief Executive Officer, Heather Dixon, President and Chief Operating Officer and Brian Poff, E

    11/5/25 11:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare Announces Third Quarter 2025 Financial Results

    Expands in Texas with Acquisition of Personal Care Operations of Del Cielo Home Care Services Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2025. Third Quarter 2025 Highlights: Net Service Revenues Grow 25.0% to $362.3 Million Net Income of $22.8 Million, or $1.24 per Diluted Share Adjusted Net Income per Diluted Share Increases 20.0% year-over-year to $1.56 Adjusted EBITDA Increases 31.6% year-over-year to $45.1 Million Cash Flow from Operations of $51.3 Million Completed Del Cielo acquisition on October 1, 2025 Overview Net service revenu

    11/3/25 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Truist initiated coverage on Addus HomeCare with a new price target

    Truist initiated coverage of Addus HomeCare with a rating of Buy and set a new price target of $135.00

    1/7/26 9:08:42 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    BMO Capital Markets initiated coverage on Addus HomeCare with a new price target

    BMO Capital Markets initiated coverage of Addus HomeCare with a rating of Market Perform and set a new price target of $120.00

    11/13/25 9:11:54 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    UBS initiated coverage on Addus HomeCare with a new price target

    UBS initiated coverage of Addus HomeCare with a rating of Buy and set a new price target of $145.00

    9/2/25 8:34:27 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Addus HomeCare Corporation

    SCHEDULE 13G/A - Addus HomeCare Corp (0001468328) (Subject)

    2/12/26 10:25:43 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Addus HomeCare Corporation

    SCHEDULE 13G/A - Addus HomeCare Corp (0001468328) (Subject)

    2/10/26 5:19:18 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    SEC Form 144 filed by Addus HomeCare Corporation

    144 - Addus HomeCare Corp (0001468328) (Subject)

    12/5/25 4:02:35 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Financials

    Live finance-specific insights

    View All

    Addus HomeCare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the fourth quarter and year-ended December 31, 2025, on Monday, February 23, 2026, after the market close. Addus HomeCare will host a conference call on Tuesday, February 24, 2026, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather Dixon, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available

    2/9/26 11:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare Announces Third Quarter 2025 Financial Results

    Expands in Texas with Acquisition of Personal Care Operations of Del Cielo Home Care Services Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2025. Third Quarter 2025 Highlights: Net Service Revenues Grow 25.0% to $362.3 Million Net Income of $22.8 Million, or $1.24 per Diluted Share Adjusted Net Income per Diluted Share Increases 20.0% year-over-year to $1.56 Adjusted EBITDA Increases 31.6% year-over-year to $45.1 Million Cash Flow from Operations of $51.3 Million Completed Del Cielo acquisition on October 1, 2025 Overview Net service revenu

    11/3/25 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare Announces Third Quarter 2025 Earnings Release and Conference Call

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2025, on Monday, November 3, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, November 4, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather Dixon, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through mid

    10/20/25 11:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Addus HomeCare Corporation

    SC 13G - Addus HomeCare Corp (0001468328) (Subject)

    11/13/24 9:44:25 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

    SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

    2/13/24 4:55:59 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

    SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

    1/22/24 2:03:09 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Leadership Updates

    Live Leadership Updates

    View All

    Addus HomeCare Names Heather Dixon President and Chief Operating Officer

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced that Heather Dixon has been appointed President and Chief Operating Officer of Addus and is expected to join the Company in that role in mid-September. W. Bradley Bickham, the Company's current President and Chief Operating Officer, has been appointed advisor to the Chief Executive Officer upon Dixon joining and has agreed to serve in that role until his previously announced retirement in March 2026. Commenting on today's announcement, Dirk Allison, Chairman and Chief Executive Officer, stated, "We are excited to welcome Heather Dixon as our new President and Chief Operating Officer. Heather's exte

    8/7/25 8:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Axonics® Announces Appointment of Dr. Esteban López to its Board of Directors

    Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the appointment of Esteban López, M.D., MBA, to its board of directors, effective immediately. "Axonics is fortunate to have someone of Dr. López's character and extensive experience join our board of directors," said Raymond W. Cohen, CEO of Axonics. "Given his thought leadership in healthcare, Dr. López will be a valuable adviser to Axonics as we continue to execute on our ambitious growth objectives." Dr. López is the Americas healthcare and life sciences Market Lead at Google Cloud with multinational

    7/15/21 6:00:00 AM ET
    $AXNX
    $ADUS
    Medical/Dental Instruments
    Health Care
    Medical/Nursing Services

    Addus HomeCare Announces Retirement of Laurie Manning

    Robby Stevenson Named Company's Chief Human Resource Officer Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that Laurie Manning retired from her position as Executive Vice President and Chief Human Resource Officer, effective June 11, 2021. Robby Stevenson, Senior Vice President of Human Resources, has been promoted to Executive Vice President and Chief Human Resource Officer and will assume leadership in that area. Commenting on the announcement, Dirk Allison, Chairman and Chief Executive Officer, said, "Laurie has played an important role in the growth and success of Addus since she joined the Company in 2017. Our employees are our most impor

    6/14/21 8:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care